Hi everyone, we have been made aware of a survey run by Macmillan Cancer Support to better understand patient experiences of treatment-guiding biomarker tests in the UK.
If you are living in the UK and have had a glioblastoma diagnosis in the past ten years, we would be grateful if you could fill out the following survey.
It will take approximately 10 minutes of your time: learn.az/6043gy1Nv
This survey will be running throughout June 2024.
This project has been developed as part of a Patient Advocacy Group Partnership between Macmillan Cancer Support and AstraZeneca UK Limited. AstraZeneca has provided funding to cover the costs associated with the project.
AstraZeneca and Macmillan Cancer Support will publish the findings from this data in aggregated, anonymised form as part of a research report.